Gliknik
Manufacturing · Maryland, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
801 W Baltimore St Ste 501A, Baltimore, ...Phone Number
(410) 685-0662Website
www.gliknik.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Gliknik
Gliknik is a biotechnology company focused on discovering and developing innovative biologics for individuals with immune disorders. They are advancing multiple drug candidates, including GL-2045 and GL-0719, which target autoimmune diseases and cancers. Their approach emphasizes the modulation of the immune system, leveraging a team of talented scientists and a network of global experts. Gliknik aims to provide new treatment options for patients suffering from conditions like immune thrombocytopenia and Cold Agglutinin Disease.Explore more
Gliknik Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gliknik your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Gliknik recently announced quarterly report
Product Launch: Get notified when Gliknik launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Gliknik is spiking on competitors!
Funding: Get notified immidiatlly once Gliknik has new funding data
Check if Gliknik has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Gliknik
Gliknik, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Gliknik had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Gliknik
Find more new buyers
Compare Similar Companies to Gliknik
Compare insights from companies similar to Gliknik, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Gliknik is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Gliknik is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Gliknik.
Gliknik financials insights
Gather financial insights about Gliknik, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2008
Series A
$2.9M
2010
Unspecified
$2.4M
Unspecified
$849K
2011
Unspecified
$3.5M
Unspecified
$2M
2012
Private Equity
$9.9M
Series B
$4.9M
2013
Unspecified
$2.8M
2021
Debt
$148K
Series C
$11.5M
2025
Debt
$11M
Gliknik Tech Stack
A closer look at the technologies used by Gliknik
See more technologies
Most Recent Scoops
Funding
Funding
Funding
Funding
Gliknik has received an SBA PPP loan in the amount of $148,500 from First National Bank of Pennsylvania resulting in the retention of 6 jobs.
Funding
Gliknik News & Media
Gliknik To Receive $15 Million Milestone Payment From Pfizer Inc. Following Clinical Progress With PF-06755347, Previously Known As GL-2045
BALTIMORE, Feb. 19, 2019 /PRNewswire/ -- Gliknik Inc. today announced that it will receive a $15 million milestone payment from Pfizer Inc. (NYSE: PFE) following the start of a Phase I clinical trial of Pfizer drug candidate PF-06755347, previously known as GL-2045, for the potential...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gliknik
Sign Up For FreeTo access detailed company insights
Gliknik is a biotechnology company focused on discovering and developing innovative biologics for individuals with immune disorders. They are advancing multiple drug candidates, including GL-2045 and GL-0719, which target autoimmune diseases and cancers. Their approach emphasizes the modulation of the immune system, leveraging a team of talented sc... Read More
